Similarly, humans with detectable titres of anti-GM-CSF auto-antibodies show an increased susceptibility to pulmonary tuberculosis compared to healthy controls, whilst GM-CSF immunotherapy can contribute to the resolution of disease due to drug-resistant M. tuberculosis93,94. The gene discussed is CSF2; the disease is pulmonary tuberculosis.